AMNEAL PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.745 USD | -2.10% |
|
-1.53% | +11.12% |
Presenter SpeechChirag Patel (Executives)Thank you for coming this afternoon and a nice weathe...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Amneal Pharmaceuticals, Inc., is a fully integrated global essential medicine company. The Company is engaged in the development, manufacturing, and distribution of a diverse portfolio of approximately 270 pharmaceutical products, primarily within the United States. The Companyâs Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermal across a broad range of therapeutic categories. The Company's Specialty segmentâs portfolio includes central nervous system disorders (Parkinsonâs disease, spasticity, migraine), endocrinology (hypothyroidism), and other therapeutic areas. The Companyâs AvKARE segment provides pharmaceuticals, medical and surgical products, and services to government, retail, and institutional markets.
Sector
Pharmaceuticals
Calendar
04/08/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
6.75
USD
Average target price
8.25
USD
Spread / Average Target
+22.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.12% | 2.08B | |
| +51.82% | 797B | |
| +40.44% | 628B | |
| -6.88% | 351B | |
| +16.95% | 323B | |
| +9.49% | 300B | |
| +16.87% | 244B | |
| +0.94% | 223B | |
| +5.30% | 163B | |
| -6.29% | 153B |
- Stock Market
- Equities
- AMRX Stock
- News Amneal Pharmaceuticals, Inc.
- Transcript : Amneal Pharmaceuticals, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 01
